Fabio
8.7 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Health insurance; authorization of drug prescribed for the treatment of a mental disorder. | Health insurance; authorization of drug prescribed for the treatment of a mental disorder. Requires that any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, contain provisions that require, when a carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization can be required if (i) the drug is a covered benefit, (ii) the prescription does not exceed the U.S. Food and Drug Administration-labeled dosages, (iii) the prescription has been continuously issued for no fewer than three months, and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. The bill provides that this requirement does not prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription is issued. The bill also provides that such provider contracts contain provisions requiring a carrier to honor a prior authorization issued by the carrier for a drug regardless if the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued. | us/states/va | Virginia General Assembly | 2021 | HB 2008 | Virginia HB 2008 (2021) |
|
enacted |
|
5 | 39 | 10 | 2021-01-11 | 2021-03-11 | openstates | ocd-bill/fa41c078-0cca-4cc7-b5a2-5498d2df25e4 | https://lis.virginia.gov/cgi-bin/legp604.exe?212+sum+HB2008 | 9add66ddff85abc8d194cda8f4deba8fd48fd198e251a752726c1fda35f1fd96 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 2008 (2021) — Health insurance; authorization of drug prescribed for the treatment of a mental disorder.
Health insurance; authorization of drug prescribed for the treatment of a mental disorder. Requires that any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, contain provisions that require, when a carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization can be required if (i) the drug is a covered benefit, (ii) the prescription does not exceed the U.S. Food and Drug Administration-labeled dosages, (iii) the prescription has been continuously issued for no fewer than three months, and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. The bill provides that this requirement does not prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription is issued. The bill also provides that such provider contracts contain provisions requiring a carrier to honor a prior authorization issued by the carrier for a drug regardless if the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0066 (committee substitute) — source
- Committee substitute printed 21103490D-H1 (committee substitute) — source
- Committee substitute printed 21200210D-S1 (committee substitute) — source
- HB2008ER (committee substitute) — source
- Prefiled and ordered printed; offered 01/13/21 21101077D (committee substitute) — source
Votes
- Passed Senate with substitute (39-Y 0-N) — 39–0 (pass) · upper
- Reported from Commerce and Labor with substitute (15-Y 0-N) — 15–0 (pass) · upper
- VOTE: Adoption (98-Y 0-N) — 97–0 (pass) · lower
- Passed Senate with substitute (38-Y 0-N) — 38–0 (pass) · upper
- Reconsideration of Senate passage agreed to by Senate (39-Y 0-N) — 39–0 (pass) · upper
- VOTE: Block Vote Passage (99-Y 0-N) — 98–0 (pass) · lower
- Subcommittee recommends reporting with substitute (8-Y 0-N) — 8–0 (pass) · lower
- Continued to 2021 Sp. Sess. 1 in Commerce and Labor (15-Y 0-N) — 15–0 (pass) · upper
- Reported from Labor and Commerce with substitute (22-Y 0-N) — 22–0 (pass) · lower
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
Sponsors
- Steve E. Heretick — primary (person)
- Dan I. Helmer — cosponsor (person)
- David A. Reid — cosponsor (person)
- Dawn M. Adams — cosponsor (person)
- Glenn R. Davis — cosponsor (person)
- Ibraheem S. Samirah — cosponsor (person)
- Kaye Kory — cosponsor (person)
- Marcus B. Simon — cosponsor (person)
- Mark H. Levine — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-01-11 Prefiled and ordered printed; offered 01/13/21 21101077D
introduction - 2021-01-11 Referred to Committee on Labor and Commerce
referral-committee - 2021-01-14 Assigned L & C sub: Subcommittee #2
referral-committee - 2021-01-20 Impact statement from DPB (HB2008)
- 2021-01-21 House subcommittee amendments and substitutes offered
- 2021-01-21 Subcommittee recommends reporting with substitute (8-Y 0-N)
- 2021-01-26 Reported from Labor and Commerce with substitute (22-Y 0-N)
committee-passage - 2021-01-26 Committee substitute printed 21103490D-H1
substitution - 2021-01-27 Read first time
reading-1 - 2021-01-28 Read second time
reading-2 - 2021-01-28 Committee substitute agreed to 21103490D-H1
- 2021-01-28 Engrossed by House - committee substitute HB2008H1
- 2021-01-29 Impact statement from DPB (HB2008H1)
- 2021-01-29 Read third time and passed House BLOCK VOTE (99-Y 0-N)
passage, reading-3 - 2021-01-29 VOTE: Block Vote Passage (99-Y 0-N)
- 2021-02-01 Constitutional reading dispensed
- 2021-02-01 Referred to Committee on Commerce and Labor
referral-committee - 2021-02-05 Continued to 2021 Sp. Sess. 1 in Commerce and Labor (15-Y 0-N)
- 2021-02-15 Reported from Commerce and Labor with substitute (15-Y 0-N)
committee-passage - 2021-02-15 Committee substitute printed 21200210D-S1
substitution - 2021-02-17 Constitutional reading dispensed (39-Y 0-N)
- 2021-02-17 Impact statement from DPB (HB2008S1)
- 2021-02-18 Read third time
reading-3 - 2021-02-18 Reading of substitute waived
- 2021-02-18 Committee substitute agreed to 21200210D-S1
- 2021-02-18 Engrossed by Senate - committee substitute HB2008S1
- 2021-02-18 Passed Senate with substitute (38-Y 0-N)
passage - 2021-02-18 Reconsideration of Senate passage agreed to by Senate (39-Y 0-N)
- 2021-02-18 Passed Senate with substitute (39-Y 0-N)
passage - 2021-02-22 Placed on Calendar
- 2021-02-22 Senate substitute agreed to by House 21200210D-S1 (98-Y 0-N)
- 2021-02-22 VOTE: Adoption (98-Y 0-N)
- 2021-02-25 Enrolled
- 2021-02-25 Signed by President
- 2021-02-26 Impact statement from DPB (HB2008ER)
- 2021-02-26 Signed by Speaker
- 2021-03-01 Enrolled Bill communicated to Governor on March 1, 2021
- 2021-03-01 Governor's Action Deadline 11:59 p.m., March 31, 2021
- 2021-03-11 Approved by Governor-Chapter 66 (effective 7/1/21)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/fa41c078-0cca-4cc7-b5a2-5498d2df25e4. Confidence: reported (aggregated from official Virginia legislature records).